
Ipratropium (0.06% w/v) + Xylometazoline (0.05% w/v)
Active composition
+1 more active ingredient
Xylometazoline stimulates alpha-adrenergic receptors, leading to vasoconstriction and reduced nasal mucosal swelling.
Medical applications
Nazeflo-XI Nasal Spray is a dual-action nasal medication containing Xylometazoline (0.05% w/v) and Ipratropium (0.06% w/v). This combination provides relief for nasal congestion, rhinorrhea, and sneezing associated with allergic and non-allergic rhinitis. Xylometazoline, a sympathomimetic decongestant, reduces vasodilation in the nasal mucosa, thereby decreasing congestion. Ipratropium, an anticholinergic, inhibits the action of acetylcholine, reducing mucus secretion and inflammation. Nazeflo-XI Nasal Spray is for topical nasal application only and should be used as directed by a healthcare professional. Consult a healthcare provider before using Nazeflo-XI Nasal Spray if you have heart disease, high blood pressure, thyroid disease, diabetes, or glaucoma, or if you are pregnant or breastfeeding.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nazeflo-XI Nasal Spray may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Nazeflo-XI Nasal Spray is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Nazeflo-XI Nasal Spray

Xylometazoline (0.05% w/v) + Ipratropium (0.06% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Xylometazoline stimulates alpha-adrenergic receptors, leading to vasoconstriction and reduced nasal mucosal swelling.
Medical applications
Nazeflo-XI Nasal Spray is a dual-action nasal medication containing Xylometazoline (0.05% w/v) and Ipratropium (0.06% w/v). This combination provides relief for nasal congestion, rhinorrhea, and sneezing associated with allergic and non-allergic rhinitis. Xylometazoline, a sympathomimetic decongestant, reduces vasodilation in the nasal mucosa, thereby decreasing congestion. Ipratropium, an anticholinergic, inhibits the action of acetylcholine, reducing mucus secretion and inflammation. Nazeflo-XI Nasal Spray is for topical nasal application only and should be used as directed by a healthcare professional. Consult a healthcare provider before using Nazeflo-XI Nasal Spray if you have heart disease, high blood pressure, thyroid disease, diabetes, or glaucoma, or if you are pregnant or breastfeeding.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nazeflo-XI Nasal Spray may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Nazeflo-XI Nasal Spray is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Nazeflo-XI Nasal Spray